Search
for
Sort by
Research 601–630 of 1000+
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- The role of lipids in promoting hair growth through HIF-1 signaling pathway
- 877 Small T antigen from a folliculotropic polyomavirus activates canonical Wnt/β-catenin signaling in vivo
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Signaling pathways in hair aging
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- RhoA promotes epidermal stem cell proliferation via PKN1-cyclin D1 signaling
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Successive Release of Tissue Inhibitors of Metalloproteinase-1 Through Graphene Oxide-Based Delivery System Can Promote Skin Regeneration
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Exosomes derived from Umbilical cord mesenchymal stem cell promote hair regrowth in C57BL6 mice through upregulation of the RAS/ERK signaling pathway
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Hair loss and Hedgehog inhibitors: a class effect?
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review